Comparable efficacy and lower cost of PBSC mobilization with intermediate-dose cyclophosphamide and G-CSF compared with plerixafor and G-CSF in patients with multiple myeloma treated with novel therapies

F. Awan, S. T. Kochuparambil, D. E. Falconer, A. Cumpston, S. Leadmon, K. Watkins, D. Deremer, A. Jillella, M. Craig, M. Hamadani

Research output: Contribution to journalArticlepeer-review

37 Scopus citations

Fingerprint

Dive into the research topics of 'Comparable efficacy and lower cost of PBSC mobilization with intermediate-dose cyclophosphamide and G-CSF compared with plerixafor and G-CSF in patients with multiple myeloma treated with novel therapies'. Together they form a unique fingerprint.

Medicine & Life Sciences